Literature DB >> 12796699

Dimethyl sulfoxide: does it change the functional properties of the bladder wall?

Diethild Melchior1, C Subah Packer, Tomalyn C Johnson, Martin Kaefer.   

Abstract

PURPOSE: Dimethyl sulfoxide (DMSO) is used in a 50% solution to treat interstitial cystitis. Symptomatic relief occurs in about two-thirds of cases. The mechanism of action and effects of DMSO on bladder tissue function are poorly understood. Therefore, the effect of DMSO on bladder muscle compliance and contractility was evaluated.
MATERIALS AND METHODS: Contractility and compliance were evaluated in rat bladder strips exposed to various concentrations of DMSO for 7 minutes, followed by 7 to 60-minute washout periods. The effect of DMSO at concentrations of 25%, 30%, 35%, 40% and 50% on electrical field stimulation induced contractions was assessed. Acetylcholine and high KCl (Sigma Chemical Co.) induced contractions were measured after exposure to 30% DMSO. Compliance was evaluated after exposure to 30% and 50% DMSO.
RESULTS: Exposure to 40% DMSO completely abolished electrical field stimulation contractions, while 30% DMSO decreased the electrical field stimulation contraction to 40% +/- 6% of the initial force but there was almost complete recovery within 30 minutes. Contractile force was unaltered by 25% DMSO. Acetylcholine and KCl stimulation after exposure to 30% DMSO produced contractile forces of 78% +/- 6% and 39% +/- 6% of pre-DMSO control contractions, respectively. Compliance decreased by 2.4 and 4.6-fold following 30% and 50% DMSO exposure, respectively.
CONCLUSIONS: DMSO completely and irreversibly abolishes contractions at a 40% concentration. Compliance is altered at even lower concentrations (30%). These findings bring into question the current practice of treating patients who have IC with 50% DMSO. Lower concentrations (25%) of DMSO may serve as a safe, effective analgesic and anti-inflammatory treatment for IC and other bladder pathologies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12796699     DOI: 10.1097/01.ju.0000071520.73686.3d

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Intravesical dimethyl sulfoxide inhibits acute and chronic bladder inflammation in transgenic experimental autoimmune cystitis models.

Authors:  Ronald Kim; Wujiang Liu; Xiaohong Chen; Karl J Kreder; Yi Luo
Journal:  J Biomed Biotechnol       Date:  2010-11-11

Review 2.  Treatment approaches for painful bladder syndrome/interstitial cystitis.

Authors:  Theoharis C Theoharides
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Herpes simplex virus vector-mediated gene delivery for the treatment of lower urinary tract pain.

Authors:  W F Goins; J R Goss; M B Chancellor; W C de Groat; J C Glorioso; N Yoshimura
Journal:  Gene Ther       Date:  2009-02-26       Impact factor: 5.250

4.  Dimethyl sulphoxide relaxes rabbit detrusor muscle by decreasing the Ca2+ sensitivity of the contractile apparatus.

Authors:  K-i Shiga; K Hirano; J Nishimura; N Niiro; S Naito; H Kanaide
Journal:  Br J Pharmacol       Date:  2007-06-04       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.